175 related articles for article (PubMed ID: 17014556)
1. Diuretics: a modern day treatment option?
Gallagher M; Perkovic V; Chalmers J
Nephrology (Carlton); 2006 Oct; 11(5):419-27. PubMed ID: 17014556
[TBL] [Abstract][Full Text] [Related]
2. [Role of diuretics in the treatment of hypertension: from large controlled trials to international guidelines].
Chalmers J
Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():39-43. PubMed ID: 8952812
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
4. Lessons from ALLHAT. Are low budget diuretics first line therapy in hypertension?
Unger T
Z Kardiol; 2004 May; 93(5):349-56. PubMed ID: 15160270
[TBL] [Abstract][Full Text] [Related]
5. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
6. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
7. [French as 2005-recommendations on the management of arterial hypertension].
Chamontin B; Halimi JM
Arch Mal Coeur Vaiss; 2007 Jan; 100(1):42-6. PubMed ID: 17405553
[TBL] [Abstract][Full Text] [Related]
8. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
White WB
Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications of recent megatrials: in favor of old drugs.
Salvetti A; Salvetti G; Cipriano A; Virdis A; Ghiadoni L
J Nephrol; 2007; 20 Suppl 12():S4-S11. PubMed ID: 18050142
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of antihypertensive therapy with diuretics.
Fukuda M; Kimura G
Hypertens Res; 2006 Sep; 29(9):645-53. PubMed ID: 17249519
[TBL] [Abstract][Full Text] [Related]
13. Diuretics in hypertension.
Valvo E; D'Angelo A; Maschio G
Kidney Int Suppl; 1997 Jun; 59():S36-8. PubMed ID: 9185102
[TBL] [Abstract][Full Text] [Related]
14. Doxazosin in the current treatment of hypertension.
Wykretowicz A; Guzik P; Wysocki H
Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
[TBL] [Abstract][Full Text] [Related]
15. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
16. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
17. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
19. Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.
Papadopoulos DP; Papademetriou V
Clin Exp Hypertens; 2007 Nov; 29(8):503-16. PubMed ID: 18058476
[TBL] [Abstract][Full Text] [Related]
20. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
